Quaero Capital S.A. - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Quaero Capital S.A. ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$1,042,440
+35.4%
1,200,000
+33.3%
0.99%
+67.4%
Q2 2023$769,635
+0.2%
900,0000.0%0.59%
+5.5%
Q1 2023$768,420
+2.5%
900,0000.0%0.56%
+8.3%
Q4 2022$749,826
+4.3%
900,0000.0%0.52%
-8.0%
Q3 2022$719,000
+0.8%
900,0000.0%0.56%
-1.6%
Q2 2022$713,000
-5.8%
900,0000.0%0.57%
+118.3%
Q1 2022$757,000900,0000.26%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders